Carisma Therapeutics Total Liabilities

Carisma Therapeutics (CARM) currently reports a total liabilities of $7.4M as of September 2025. That compares with $53M in the prior-year period — down 86.0% year over year. Use the charts on this page to explore Carisma Therapeutics's total liabilities history and peer comparisons.

Carisma Therapeutics's total liabilities decreased from $53M to $7.4M — a 86.0% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Carisma Therapeutics reported $7.4M in total liabilities as of September 2025. That compares with $53M in the prior-year period — down 86.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $7.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Carisma Therapeutics, and consider following CARM for alerts when major investors trade the stock.

Carisma Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $7.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CARM with unrelated industries.